Study title:
Rosenberg-S-A, Kaplan-H-S.
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
International journal of radiation oncology biology physics, {Int-J-Radiat-Oncol-Biol-Phys}, Jan 1985, vol. 11, no. 1, p. 5-22, ISSN: 0360-3016.Rosenberg-S-A, Kaplan-H-S.
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
International journal of radiation oncology biology physics, {Int-J-Radiat-Oncol-Biol-Phys}, Jan 1985, vol. 11, no. 1, p. 5-22, ISSN: 0360-3016.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|